Table 3 Sociodemographic and clinical characteristics of people referred to GL-CS
Sociodemographic characteristics (n = 39) | ||
Place of birth | n | % |
Oceania (Australia, NZ) | 24 | 61 |
Europe (England, Italy, Netherlands) | 7 | 18 |
Asia (Iran, Malaysia, Sri Lanka, China, Hong Kong) | 5 | 13 |
Africa (Egypt, South Africa) | 2 | 5 |
Unknown | 1 | 3 |
Language spoken at home | ||
English | 34 | 87 |
Other (Dutch, mandarin, Cantonese, Persian) | 5 | 13 |
Socio-economic Index for area # | ||
Quintile 1 | 0 | 0 |
Quintile 2 | 1 | 3 |
Quintile 3 | 3 | 8 |
Quintile 4 | 17 | 43 |
Quintile 5 | 18 | 46 |
Accessibility/Remoteness index for Australia | ||
Major Cities | 37 | 95 |
Inner Regional | 2 | 5 |
Clinical characteristics (n = 38) | ||
Cancer type | ||
Lung | 11 | 29 |
Breast | 11 | 29 |
Bladder | 7 | 18 |
Other (Prostate, Colorectal, | 9 | 24 |
Cancer stage | ||
Non-metastatic (Stage 0-III) | 18 | 47 |
Metastatic (stage IV) | 14 | 37 |
Unknown | 6 | 16 |
Time since diagnosis (years) | ||
<= 1 | 17 | 45 |
> 1–3 | 12 | 31 |
> 3–5 | 6 | 16 |
> 5–10 | 3 | 8 |
Type of treatment received | ||
Immunotherapy | 22 | 58 |
Surgery | 19 | 50 |
Chemotherapy | 18 | 47 |
Radiation therapy | 11 | 29 |
Oral therapy | 10 | 26 |